Huntsman Corporation reported fourth‑quarter 2025 results on February 17, 2026, with revenue of $1.355 billion, a 5% year‑over‑year decline, and a net loss attributable to Huntsman of $96 million. Adjusted EBITDA fell to $35 million from $71 million in the same period last year, and free cash flow from continuing operations was $20 million.
The company beat revenue expectations, generating $1.355 billion versus the consensus estimate of $1.330 billion—a $25 million or 1.9% beat. The upside was driven by the Polyurethanes segment, which posted $897 million in revenue, an 8% decline YoY but still higher than the $860 million forecast, supported by a mix shift toward higher‑margin products. Performance Products revenue also held steady, offsetting broader market softness.
Adjusted diluted earnings per share were $-0.37, missing the consensus estimate of $-0.29 by $0.08. The miss reflects margin compression from lower average selling prices and higher input costs, particularly in the Polyurethanes business where MDI margins fell sharply. The company’s cost‑reduction program has offset more than $150 million of inflationary pressure since 2022, but the pricing environment remains challenging.
Segment performance highlights that Polyurethanes revenue declined 8% YoY to $897 million, with adjusted EBITDA dropping 50% to $25 million. Performance Products revenue fell 6% YoY, with adjusted EBITDA down 30%. Advanced Materials revenue and margins remained largely flat, providing a stabilizing effect on the overall results.
Comparing to the prior quarter, Q3 2025 adjusted EBITDA was $94 million, a stark contrast to the $35 million reported in Q4. The net loss widened, and the company’s cash flow from operations remained robust at $300 million, translating to a 45% free‑cash‑flow conversion rate.
Management emphasized that the company’s focus remains on cash generation and balance‑sheet strength. The dividend was cut to $0.0875 per share, payable March 31, 2026, to shareholders of record as of March 13, 2026. The company also reiterated its commitment to a cost‑reduction program that has already delivered $150 million in savings.
Looking ahead, Huntsman expects capital expenditures in 2026 to be comparable to 2025 levels. While management remains confident that the chemical cycle will improve over time, it acknowledges that meaningful market recovery may take longer than the current quarter.
Corporate events include the dividend cut and the announcement that the 2026 annual meeting of stockholders will be held virtually on April 29, 2026, with voting rights for holders of record as of March 6, 2026.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.